{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:59:49Z","timestamp":1772575189169,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T00:00:00Z","timestamp":1450137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Head &amp; Neck"],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The purpose of this study was to explore urinary Epstein\u2013Barr virus (EBV)\u2010DNA as a potential biomarker in patients with nasopharyngeal carcinoma (NPC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>EBV\u2010DNA copies were estimated in plasma\/urine of patients with NPC (<jats:italic>n<\/jats:italic>\u2009=\u200976) by real\u2010time polymerase chain reaction (PCR) at baseline, during therapy, and at follow\u2010up. Their correlation with EBV\u2010RNA expression in tissues (<jats:italic>n<\/jats:italic>\u2009=\u200953) was used to assess sensitivity and specificity of plasma\/urine EBV\u2010DNA. Correlation of urine and plasma EBV\u2010DNA with each other and with radiological response was evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study demonstrated that urine EBV\u2010DNA has high sensitivity (96%) at diagnosis and it correlates well with plasma EBV\u2010DNA at baseline and after neoadjuvant chemotherapy. The EBV\u2010DNA copies reduced significantly with therapy (plasma: <jats:italic>p<\/jats:italic> &lt; .001; urine: <jats:italic>p<\/jats:italic>\u2009=\u2009.011). Patients with low EBV\u2010DNA copies demonstrated improved survival (plasma: <jats:italic>p<\/jats:italic>\u2009=\u2009.023; urine: <jats:italic>p<\/jats:italic>\u2009=\u2009.083).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Plasma EBV\u2010DNA is a good prognostic marker, whereas further study on a larger cohort may help in developing urine EBV\u2010DNA as a surrogate prognostic marker for patients with NPC. \u00a9 2015 Wiley Periodicals, Inc. <jats:italic>Head Neck<\/jats:italic> <jats:bold>38<\/jats:bold>: E1666\u2013E1673, 2016<\/jats:p><\/jats:sec>","DOI":"10.1002\/hed.24297","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T06:13:03Z","timestamp":1450159983000},"source":"Crossref","is-referenced-by-count":10,"title":["Cell\u2010free Epstein\u2013Barr virus\u2010DNA in patients with nasopharyngeal carcinoma: Plasma versus urine"],"prefix":"10.1002","volume":"38","author":[{"given":"Manju","family":"Sengar","sequence":"first","affiliation":[{"name":"Department of Medical Oncology Tata Memorial Hospital, Tata Memorial Centre (TMC) Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhesh","family":"Chorghe","sequence":"additional","affiliation":[{"name":"Chiplunkar Lab, Advanced Centre for Treatment, Research &amp; Education in Cancer (ACTREC), TMC, Kharghar Navi Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamini","family":"Jadhav","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Tata Memorial Hospital, Tata Memorial Centre (TMC) Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Singh","sequence":"additional","affiliation":[{"name":"Chiplunkar Lab, Advanced Centre for Treatment, Research &amp; Education in Cancer (ACTREC), TMC, Kharghar Navi Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarbani Ghosh","family":"Laskar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prathamesh","family":"Pai","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgical Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai Prakash","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"D'Cruz","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgical Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgical Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandar","family":"Deshpande","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgical Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra","family":"Chaukar","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgical Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini","family":"Budrukkar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejpal","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology ACTREC, TMC Kharghar Navi Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vedang","family":"Murthy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubhada","family":"Kane","sequence":"additional","affiliation":[{"name":"Department of Pathology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Tata Memorial Hospital, TMC Parel Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh","family":"Rangarajan","sequence":"additional","affiliation":[{"name":"Department of Bioimaging, Tata Memorial Hospital TMC Parel Mumbai 400012 India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhana","family":"Kannan","sequence":"additional","affiliation":[{"name":"Epidemiology and Clinical Trial Unit ACTREC, TMC Kharghar Navi Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanuja","family":"Shet","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology ACTREC, TMC Kharghar Navi Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Kode","sequence":"additional","affiliation":[{"name":"Chiplunkar Lab, Advanced Centre for Treatment, Research &amp; Education in Cancer (ACTREC), TMC, Kharghar Navi Mumbai India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,12,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66698-6"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.7542"},{"key":"e_1_2_7_4_1","first-page":"1447","article-title":"Differential roles of 18F\u2010FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management","volume":"47","author":"Chan SC","year":"2006","journal-title":"J Nucl Med"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.12.4737"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920101)69:1<3::AID-CNCR2820690104>3.0.CO;2-7"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(04)00119-9"},{"key":"e_1_2_7_8_1","first-page":"1188","article-title":"Quantitative analysis of cell\u2010free Epstein\u2013Barr virus DNA in plasma of patients with nasopharyngeal carcinoma","volume":"59","author":"Lo YM","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0571"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2013.12.011"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.7982"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.02.012"},{"key":"e_1_2_7_13_1","first-page":"6878","article-title":"Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein\u2013Barr virus DNA","volume":"60","author":"Lo YM","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_7_14_1","first-page":"1","article-title":"Epidemiological and etiological factors associated with nasopharyngeal carcinoma","volume":"33","author":"Kumar S","year":"2003","journal-title":"Icmr Bull"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1112"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyh055"},{"key":"e_1_2_7_17_1","first-page":"80","article-title":"Epstein\u2013Barr virus in nasopharyngeal carcinoma in Indian patients","volume":"36","author":"Rathaur RG","year":"1999","journal-title":"Indian J Cancer"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.02.016"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.07.012"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(97)00101-8"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90530-2"},{"key":"e_1_2_7_22_1","first-page":"803","article-title":"Evaluation of plasma Epstein\u2013Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma","volume":"47","author":"Tan EL","year":"2006","journal-title":"Singapore Med J"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-454694"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.21.1614"}],"container-title":["Head &amp; Neck"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhed.24297","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhed.24297","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hed.24297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T02:05:49Z","timestamp":1694311549000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hed.24297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,15]]},"references-count":23,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1002\/hed.24297"],"URL":"https:\/\/doi.org\/10.1002\/hed.24297","archive":["Portico"],"relation":{},"ISSN":["1043-3074","1097-0347"],"issn-type":[{"value":"1043-3074","type":"print"},{"value":"1097-0347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,15]]}}}